Tumor suppressor p53 regulates heparanase gene expression

被引:86
作者
Baraz, L.
Haupt, Y.
Elkin, M.
Peretz, T.
Vlodavsky, I.
机构
[1] Hadassah Univ, Med Ctr, Dept Oncol, Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, Jerusalem, Israel
[3] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel
关键词
heparanase; p53; gene expression; promoter activity;
D O I
10.1038/sj.onc.1209425
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mammalian heparanase degrades heparan sulfate, the most prominent polysaccharide of the extracellular matrix. Causal involvement of heparanase in tumor progression is well documented. Little is known, however, about mechanisms that regulate heparanase gene expression. Mutational inactivation of tumor suppressor p53 is the most frequent genetic alteration in human tumors. p53 is a transcription factor that regulates a wide variety of cellular promoters. In this study, we demonstrate that wild-type (wt) p53 binds to heparanase promoter and inhibits its activity, whereas mutant p53 variants failed to exert an inhibitory effect. Moreover, p53-H175R mutant even activated heparanase promoter activity. Elimination or inhibition of p53 in several cell types resulted in a significant increase in heparanase gene expression and enzymatic activity. Trichostatin A abolished the inhibitory effect of wt p53, suggesting the involvement of histone deacetylation in negative regulation of the heparanase promoter. Altogether, our results indicate that the heparanase gene is regulated by p53 under normal conditions, while mutational inactivation of p53 during cancer development leads to induction of heparanase expression, providing a possible explanation for the frequent increase of heparanase levels observed in the course of tumorigenesis.
引用
收藏
页码:3939 / 3947
页数:9
相关论文
共 56 条
[1]   Remodelling chromatin on a global scale: a novel protective function of p53 [J].
Allison, SJ ;
Milner, J .
CARCINOGENESIS, 2004, 25 (09) :1551-1557
[2]   Functions of cell surface heparan sulfate proteoglycans [J].
Bernfield, M ;
Götte, M ;
Park, PW ;
Reizes, O ;
Fitzgerald, ML ;
Lincecum, J ;
Zako, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :729-777
[3]   Tumor-stroma interactions [J].
Bhowmick, NA ;
Moses, HL .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2005, 15 (01) :97-101
[4]   Regulation of inducible heparanase gene transcription in activated T cells by early growth response 1 [J].
de Mestre, AM ;
Khachigian, LM ;
Santiago, FS ;
Staykova, MA ;
Hulett, MD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (50) :50377-50385
[5]  
El-Assal ON, 2001, CLIN CANCER RES, V7, P1299
[6]   DEFINITION OF A CONSENSUS BINDING-SITE FOR P53 [J].
ELDEIRY, WS ;
KERN, SE ;
PIETENPOL, JA ;
KINZLER, KW ;
VOGELSTEIN, B .
NATURE GENETICS, 1992, 1 (01) :45-49
[7]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[8]  
Elkin M, 2003, CANCER RES, V63, P8821
[9]  
Farmer G, 1996, MOL CELL BIOL, V16, P4295
[10]   Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma -: Evidence for its role in colonic tumorigenesis [J].
Friedmann, Y ;
Vlodavsky, I ;
Aingorn, H ;
Aviv, A ;
Peretz, T ;
Pecker, I ;
Pappo, O .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (04) :1167-1175